110 related articles for article (PubMed ID: 23317312)
1. The impact of E-cadherin expression on the prognosis of esophageal cancer: a meta-analysis.
Xu XL; Ling ZQ; Chen SZ; Li B; Ji WH; Mao WM
Dis Esophagus; 2014 Jan; 27(1):79-86. PubMed ID: 23317312
[TBL] [Abstract][Full Text] [Related]
2. Decreased expression of E-cadherin and Yamamoto-Kohama's mode of invasion highly correlates with lymph node metastasis in esophageal squamous cell carcinoma.
Kaihara T; Kusaka T; Kawamata H; Oda Y; Fujii S; Morita K; Imura J; Fujimori T
Pathobiology; 2001; 69(3):172-8. PubMed ID: 11872963
[TBL] [Abstract][Full Text] [Related]
3. C-Met as a potential novel prognostic marker in squamous cell carcinoma and adenocarcinoma of esophagus: evidence from a meta-analysis.
Ren JL; Wu HF; Wang WJ; Hu GM; Gu B; Zhang M; Wang YX
Panminerva Med; 2017 Mar; 59(1):97-106. PubMed ID: 27636117
[TBL] [Abstract][Full Text] [Related]
4. Survivin over-expression is correlated with a poor prognosis in esophageal cancer patients.
Xia H; Chen S; Huang H; Ma H
Clin Chim Acta; 2015 Jun; 446():82-5. PubMed ID: 25896962
[TBL] [Abstract][Full Text] [Related]
5. E-cadherin is a selective and strongly dominant prognostic factor in squamous cell carcinoma: a comparison of E-cadherin with desmosomal components.
Bosch FX; Andl C; Abel U; Kartenbeck J
Int J Cancer; 2005 May; 114(5):779-90. PubMed ID: 15609307
[TBL] [Abstract][Full Text] [Related]
6. Vascular endothelial growth factor-C expression as a biomarker of poor prognosis in esophageal squamous cell carcinoma: a meta-analysis.
Tullavardhana T; Akranurakkul P; Ungkitphaiboon W; Songtish D
Oncol Res Treat; 2015; 38(3):110-4. PubMed ID: 25792082
[TBL] [Abstract][Full Text] [Related]
7. Fhit, E-cadherin, p53, and activation-induced cytidine deaminase expression in endoscopically resected early stage esophageal squamous neoplasia.
Hayashi A; Yashima K; Takeda Y; Sasaki S; Kawaguchi K; Harada K; Murawaki Y; Ito H
J Gastroenterol Hepatol; 2012 Nov; 27(11):1752-8. PubMed ID: 22742976
[TBL] [Abstract][Full Text] [Related]
8. alpha-catenin is a significant prognostic factor than E-cadherin in esophageal squamous cell carcinoma.
Setoyama T; Natsugoe S; Okumura H; Matsumoto M; Uchikado Y; Yokomakura N; Ishigami S; Aikou T
J Surg Oncol; 2007 Feb; 95(2):148-55. PubMed ID: 17262732
[TBL] [Abstract][Full Text] [Related]
9. Tumor budding and E-cadherin expression are useful predictors of nodal involvement in T1 esophageal squamous cell carcinoma.
Nakagawa Y; Ohira M; Kubo N; Yamashita Y; Sakurai K; Toyokawa T; Tanaka H; Muguruma K; Shibutani M; Yamazoe S; Kimura K; Nagahara H; Amano R; Ohtani H; Yashiro M; Maeda K; Hirakawa K
Anticancer Res; 2013 Nov; 33(11):5023-9. PubMed ID: 24222146
[TBL] [Abstract][Full Text] [Related]
10. The Prognostic Impact of Heat Shock Proteins Expression in Patients with Esophageal Cancer: A Meta-Analysis.
Wang XW; Shi XH; Tong YS; Cao XF
Yonsei Med J; 2015 Nov; 56(6):1497-502. PubMed ID: 26446629
[TBL] [Abstract][Full Text] [Related]
11. [Expressions of epithelial growth factor receptor and E-cadherin in esophageal carcinoma and their correlation].
Fu JH; Yang DK; Huang YC; Hu GQ
Ai Zheng; 2005 Feb; 24(2):241-5. PubMed ID: 15694044
[TBL] [Abstract][Full Text] [Related]
12. [Expression of E-cadherin in the tumor tissue and serum of patients with esophageal squamous cell carcinoma].
Zhang J; He Y; Wang S; Huang W; Chen X; He B; Zhao Y; Wang J; Zhang G
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 Mar; 37(3):228-32. PubMed ID: 22561504
[TBL] [Abstract][Full Text] [Related]
13. CyclinD1, p53, E-cadherin, and VEGF discordant expression in paired regional metastatic lymph nodes of esophageal squamous cell carcinoma: a tissue array analysis.
Luo KJ; Hu Y; Wen J; Fu JH
J Surg Oncol; 2011 Sep; 104(3):236-43. PubMed ID: 21480261
[TBL] [Abstract][Full Text] [Related]
14. The prognostic value of E-cadherin in gastric cancer: a meta-analysis.
Xing X; Tang YB; Yuan G; Wang Y; Wang J; Yang Y; Chen M
Int J Cancer; 2013 Jun; 132(11):2589-96. PubMed ID: 23169395
[TBL] [Abstract][Full Text] [Related]
15. [Histopathological and immunohistochemical evaluation of lymph node metastasis in superficial esophageal cancer--with reference to the expression of E-cadherin and alpha-catenin].
Tamura S; Shiozaki H; Kadowaki T; Inoue M; Oka H; Matsui S; Mori T
Nihon Geka Gakkai Zasshi; 1995 Aug; 96(8):550-6. PubMed ID: 7565577
[TBL] [Abstract][Full Text] [Related]
16. Expression of E-cadherin in oesophageal carcinomas from the UK and China: disparities in prognostic significance.
Jian WG; Darnton SJ; Jenner K; Billingham LJ; Matthews HR
J Clin Pathol; 1997 Aug; 50(8):640-4. PubMed ID: 9301546
[TBL] [Abstract][Full Text] [Related]
17. Altered expression of E-cadherin by hepatocyte growth factor and effect on the prognosis of nasopharyngeal carcinoma.
Xie LQ; Bian LJ; Li Z; Li Y; Li ZX; Li B
Ann Surg Oncol; 2010 Jul; 17(7):1927-36. PubMed ID: 20131016
[TBL] [Abstract][Full Text] [Related]
18. Reduced expression of the cadherin-catenin complex in oesophageal adenocarcinoma correlates with poor prognosis.
Krishnadath KK; Tilanus HW; van Blankenstein M; Hop WC; Kremers ED; Dinjens WN; Bosman FT
J Pathol; 1997 Jul; 182(3):331-8. PubMed ID: 9349237
[TBL] [Abstract][Full Text] [Related]
19. Change of E-cadherin by hepatocyte growth factor and effects on the prognosis of hypopharyngeal carcinoma.
Kim CH; Kim J; Kahng H; Choi EC
Ann Surg Oncol; 2007 May; 14(5):1565-74. PubMed ID: 17294073
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of CyclinD1 and E-Cadherin in patients with esophageal squamous cell carcinoma: multiinstitutional retrospective analysis. Research Committee on Malignancy of Esophageal Cancer, Japanese Society for Esophageal Diseases.
J Am Coll Surg; 2001 Jun; 192(6):708-18. PubMed ID: 11400964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
